Intaractable blood diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with hematological disorder; Acute myeloblastic leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, chronic lymphoid leukemia, myelodysplastic syndrome, myelofibrosis, polycythemia vera, aplastic anemia, multiple myeloma, primary macrogloblinemia, PNH) Informed consent from the patient must be obtained.
Exclusion criteria
Exclusion criteria: The patient without informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multiple element proportional and distribution analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Elemental pattern corresponding to pathogenesis | — |
Countries
Japan
Contacts
International Medical Center of Japan Hospital, Hematology division of Internal Medicine